Check out MKI MKI is pretty much EKG's twin in the vascular health field. Except MKI is a year ahead because they got their FDA approval last February. Their stock shot up from 5.5 cents to 84 cents in a couple of days, much like EKG. Their product development and marketing plan is already fully funded, no risk of share dilution.
Their software and equipment are already rolled out and they sold to 6 hospitals last month according to their news release.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical imaging software solutions that help medical practitioners to better understand lesions and critical anatomy, announced today that the Company's new Visualize:Vascular™ product has been installed and is in use with customers who occupy all market sectors: vascular surgery, cardiology and radiology. Vascular surgery practices include: Eastern Vascular Diagnostics, Bronx, NY and Northeast Philadelphia Vascular Surgeons, Philadelphia, PA. Cardiology practices include Farmingdale Heart, Farmingdale, NY. Radiology practices include: Milburn Medical Imaging, Maplewood, NJ, University Diagnostic Medical Imaging, Bronx, NY and XXI Century Radiology Imaging, Brooklyn, NY.
EKG has had a nice run and so has VV today. MKI is next. Do your own DD and you'll probably come to the same conclusion I did.